MediPharm Labs Corp. (“MediPharm Labs”) a global leader in research-driven pharmaceutical-quality cannabis extraction, distillation, and derivative products announced its wholly-owned subsidiary will supply premium, GMP-certified formulated cannabis oil to Brazil. The supply agreement is set to begin with the distributor XLR8 BRAZIL (“XLR8”), a Rio de Janeiro based value-added distributor serving Brazil. Under the two-year agreement, MediPharm Labs Inc. will provide a variety of cannabis concentrate formats for patient-ready formulated products that will be distributed by XLR8 to leading pharmacies and other authorized channels in Brazil.

Mmp News Author, Medical Marijuana Program Connection, 09/22/2020 07:27:57

Open article: